Health In Tech reported a gross margin of 48.40% and a net margin of -30.99% for the quarter ended Jun 2026. These financial ratios cover 10 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross Margin | 79.37% | 80.52% | 77.97% | 75.88% | 59.95% | 65.85% | 51.82% | 45.26% | 48.40% | |
| EBT Margin | 3.68% | 8.02% | 9.12% | -2.21% | 7.66% | 8.70% | 6.05% | -4.86% | -40.98% | |
| EBIT Margin | 6.38% | 10.69% | 9.84% | -6.32% | 5.38% | 7.57% | 4.97% | -1.87% | -42.43% | |
| EBITDA Margin | 6.38% | 10.69% | 9.84% | -6.32% | 5.38% | 7.57% | 4.97% | -1.87% | -42.43% | |
| Operating Margin | 6.38% | 10.69% | 9.84% | -6.32% | 5.38% | 7.57% | 4.97% | -1.87% | -42.43% | |
| Net Margin | 0.78% | 6.76% | 7.81% | -3.01% | 5.20% | 6.25% | 4.56% | -2.73% | -30.99% | |
| FCF Margin | -15.62% | 23.44% | 46.03% | -22.73% | -1.97% | 5.96% | -0.71% | -4.17% | ||
| Efficiency | ||||||||||
| Assets AverageAssets Avg. | 18.55M | 21.75M | 22.47M | 22.92M | 26.36M | |||||
| Invested CapitalInvested Cap. | 7.74M | |||||||||
| Asset Utilization RatioAsset Util. | 1.26 | 1.29 | 1.49 | 1.64 | 1.39 | |||||
| Leverage & Solvency | ||||||||||
| Interest Coverage RatioInterest Cover | 2.01 | 3.24 | 2.66 | 98.70 | -0.45 | -65.69 | ||||
| Debt Ratio | 0.14 | |||||||||
| Times Interest Earned | 2.01 | 3.24 | 2.66 | 98.70 | -0.45 | -65.69 | ||||
| Valuation | ||||||||||
| Price to EarningsP/E | -0.00M | 77.67 | 82.90 | 400.61 | -383.34 | -26.37 | ||||
| Price to SalesP/S | 114.02 | 4.04 | 5.18 | 18.25 | 10.45 | 8.17 | ||||
| Price to BookP/B | 43.33 | 2.55 | 3.02 | 10.56 | 5.57 | 3.37 | ||||
| Enterprise Value | 562.75M | 28.47M | 41.48M | 173.12M | 87.66M | 59.77M | ||||
| EV to EBIT | -0.00M | 59.24 | 57.21 | 350.79 | -513.22 | -17.38 | ||||
| EV to EBITDA | -0.00M | 59.24 | 57.21 | 350.79 | -513.22 | -17.38 | ||||
| Market Capitalization | 570.59M | 36.05M | 49.62M | 181.15M | 95.33M | 66.21M | ||||
| Price to FCFP/FCF | -501.72 | -204.68 | 86.85 | -0.00M | -250.55 | |||||
| EV to FCF | -494.81 | -161.67 | 72.60 | -0.00M | -230.39 | |||||
| EV to CFO | -0.00M | 53.99 | 28.01 | 256.87 | 194.29 | |||||
| Return Ratios | ||||||||||
| Return on Sales [ROS]ROS | 6.38% | 10.69% | 9.84% | -6.32% | 5.38% | 7.57% | 4.97% | -1.87% | -42.43% | |
| Return on Capital Employed [ROCE]ROCE | 9.65% | 8.12% | 8.03% | 8.60% | -14.60% | |||||
| Return on Assets [ROA]ROA | 5.39% | 5.79% | 6.07% | 5.52% | -6.48% |